Patrick J Heron - Net Worth and Insider Trading
Patrick J Heron Net Worth
The estimated net worth of Patrick J Heron is at least $698 Million dollars as of 2025-01-12. Patrick J Heron is the Director of Vaxcyte Inc and owns about 2,309,554 shares of Vaxcyte Inc (PCVX) stock worth over $187 Million. Patrick J Heron is the Director of Mirum Pharmaceuticals Inc and owns about 3,729,220 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $154 Million. Patrick J Heron is also the Director of Arcutis Biotherapeutics Inc and owns about 8,817,666 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $122 Million. Besides these, Patrick J Heron also holds Imago BioSciences Inc (IMGO) , MBX Biosciences Inc (MBX) , Collegium Pharmaceutical Inc (COLL) , Passage Bio Inc (PASG) , Cidara Therapeutics Inc (CDTX) , Iterum Therapeutics PLC (ITRM) . Details can be seen in Patrick J Heron's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick J Heron has not made any transactions after 2024-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patrick J Heron
Patrick J Heron Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick J Heron owns 20 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , Iterum Therapeutics PLC (ITRM) , and Vaxcyte Inc (PCVX) among others .
Click here to see the complete history of Patrick J Heron’s form 4 insider trades.
Insider Ownership Summary of Patrick J Heron
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TARS | Tarsus Pharmaceuticals Inc | 2020-10-15 | 10 percent owner |
ITRM | Iterum Therapeutics PLC | 2019-05-24 | director & 10 percent owner |
PCVX | Vaxcyte Inc | 2020-06-16 | director |
2019-10-24 | 10 percent owner | ||
2024-09-18 | director & 10 percent owner | ||
2020-03-03 | director & 10 percent owner | ||
2024-03-04 | director & 10 percent owner | ||
2018-09-25 | 10 percent owner | ||
2017-07-24 | 10 percent owner | ||
2018-06-20 | 10 percent owner | ||
2017-01-25 | 10 percent owner | ||
2017-02-14 | 10 percent owner | ||
2016-11-01 | director | ||
2015-05-12 | director & 10 percent owner | ||
2015-06-24 | 10 percent owner | ||
2015-04-20 | director | ||
2021-07-20 | director | ||
2020-12-08 | director | ||
2022-04-28 | director & 10 percent owner | ||
2020-12-08 | director |
Patrick J Heron Latest Holdings Summary
Patrick J Heron currently owns a total of 9 stocks. Among these stocks, Patrick J Heron owns 2,309,554 shares of Vaxcyte Inc (PCVX) as of June 16, 2020, with a value of $187 Million and a weighting of 26.81%. Patrick J Heron owns 3,729,220 shares of Mirum Pharmaceuticals Inc (MIRM) as of September 18, 2024, with a value of $154 Million and a weighting of 22.06%. Patrick J Heron also owns 8,817,666 shares of Arcutis Biotherapeutics Inc (ARQT) as of March 4, 2024, with a value of $122 Million and a weighting of 17.44%. The other 6 stocks Imago BioSciences Inc (IMGO) , MBX Biosciences Inc (MBX) , Collegium Pharmaceutical Inc (COLL) , Passage Bio Inc (PASG) , Cidara Therapeutics Inc (CDTX) , Iterum Therapeutics PLC (ITRM) have a combined weighting of 33.69% among all his current holdings.
Latest Holdings of Patrick J Heron
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PCVX | Vaxcyte Inc | 2020-06-16 | 2,309,554 | 81.08 | 187,258,638 |
MIRM | Mirum Pharmaceuticals Inc | 2024-09-18 | 3,729,220 | 41.32 | 154,091,370 |
ARQT | Arcutis Biotherapeutics Inc | 2024-03-04 | 8,817,666 | 13.81 | 121,771,967 |
IMGO | Imago BioSciences Inc | 2021-07-20 | 2,971,274 | 36.01 | 106,995,577 |
MBX | MBX Biosciences Inc | 2024-09-16 | 4,552,774 | 13.69 | 62,327,476 |
COLL | Collegium Pharmaceutical Inc | 2015-05-12 | 1,887,332 | 32.91 | 62,112,096 |
PASG | Passage Bio Inc | 2020-03-03 | 5,009,219 | 0.67 | 3,356,177 |
CDTX | Cidara Therapeutics Inc | 2015-04-20 | 14,551 | 24.00 | 349,224 |
ITRM | Iterum Therapeutics PLC | 2018-05-30 | 102,554 | 1.65 | 169,214 |
Holding Weightings of Patrick J Heron
Patrick J Heron Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick J Heron has made a total of 1 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vaxcyte Inc is the acquisition of 250,000 shares on June 16, 2020, which cost Patrick J Heron around $4 Million.
According to the SEC Form 4 filings, Patrick J Heron has made a total of 6 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 115 shares on September 18, 2024, which cost Patrick J Heron around $4,301.
According to the SEC Form 4 filings, Patrick J Heron has made a total of 2 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the acquisition of 21,052 shares on March 4, 2024, which cost Patrick J Heron around $199,994.
More details on Patrick J Heron's insider transactions can be found in the Insider Trading History of Patrick J Heron table.Insider Trading History of Patrick J Heron
- 1
Patrick J Heron Trading Performance
GuruFocus tracks the stock performance after each of Patrick J Heron's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick J Heron is 7.07%. GuruFocus also compares Patrick J Heron's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick J Heron within 3 months outperforms 9 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patrick J Heron's insider trading performs compared to the benchmark.
Performance of Patrick J Heron
Patrick J Heron Ownership Network
Ownership Network List of Patrick J Heron
Ownership Network Relation of Patrick J Heron
Patrick J Heron Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Patrick J Heron is the 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Patrick J Heron made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 194,315 shares made by Bobak R. Azamian , a net sale of 12,792 shares made by Bryan Wahl , and a net sale of 12,669 shares made by Dianne C. Whitfield .
In summary, during the past 3 months, insiders sold 0 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 281,122 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 270,616 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Patrick J Heron Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick J Heron. You might contact Patrick J Heron via mailing address: 550 Hamilton Ave., Suite 100, Palo Alto Ca 94301.